The white and pale patches on the skin result in the disease called Vitiligo. They then turn widen and make appearance on other body parts. A lot of research is done on this skin disorder that psychologically harms the patients. The medical field is all the time busy in doing studies on Vitiligo to generate the actual treatment, which still has not been explored but the researchers are adamant to discover it soon.
Positive observations by the Clinuvel US Vitiligo Study done on the patients shows the positive observations. Initial study was done on the 21 patients with this disease. Later two classifications of the patients were done in which the 50% patients were undergoing repigmentation treatment with narrowband ultraviolet B treatment and the remaining 50% were undergoing for the cure of NB-UVB.
This research depicts that the initial part of the observation of the 21 patients unzips the fact that the monthly dose of the afamelanotide (16mg implant) in combination with NB-UVB consists of the capacity of gaining the faster and depth pigmentation of vitiliginous skin lesions.
The disease results in the loss of the melanin production in body that causes the loss of the white or off-white depigmented skin lesions. Around 45 million patients get affected by the non segmental vitiligo in the world.
For details, please visit:
http://vitiligocover.com/first-positive-observations-from-clinuvel-us-vitiligo-study/